top of page
A Brief Overview
A Brief Overview
A Brief Overview
Safe Harbor Statement
Home
Company Literature
About
SciTech Executive Summary
SciTech Due Diligence
FAQs
The Market
Research
Fenretinide
Fenretinide Drug Combinations
Fenretinide Use in Pediatric Cancer
Products
Clinical Trials
Oncology Product Pipeline
Contact Us
News
Equity Crowdfunding Launch
Photos
Videos
Investors
More
Use tab to navigate through the menu items.
Phase 1 Clinical Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov Identifier:
NCT04234048
Follow Us
bottom of page
